相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Increased thioredoxin-1 production in human naturally occurring regulatory T cells confers enhanced tolerance to oxidative stress
Dimitrios Mougiakakos et al.
BLOOD (2011)
T cell recognition of HLA-A2 restricted tumor antigens is impaired by the oncogene HER2
Kousaku Mimura et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
Ncf1 (p47phox) Is Essential for Direct Regulatory T Cell Mediated Suppression of CD4+Effector T Cells
Olga Efimova et al.
PLOS ONE (2011)
Molecular mechanisms regulating myeloid-derived suppressor cell differentiation and function
Thomas Condamine et al.
TRENDS IN IMMUNOLOGY (2011)
The Therapeutic Effect of Anti-HER2/neu Antibody Depends on Both Innate and Adaptive Immunity
SaeGwang Park et al.
CANCER CELL (2010)
Immune Regulatory Antibodies Are They the Next Advance?
Jedd D. Wolchok et al.
CANCER JOURNAL (2010)
Immune Stimulatory Receptor CD40 Is Required for T-Cell Suppression and T Regulatory Cell Activation Mediated by Myeloid-Derived Suppressor Cells in Cancer
Ping-Ying Pan et al.
CANCER RESEARCH (2010)
Myeloid-Derived Suppressor Cells Inhibit T-Cell Activation by Depleting Cystine and Cysteine
Minu K. Srivastava et al.
CANCER RESEARCH (2010)
Immature Immunosuppressive CD14+HLA-DR-/low Cells in Melanoma Patients Are Stat3hi and Overexpress CD80, CD83, and DC-Sign
Isabel Poschke et al.
CANCER RESEARCH (2010)
Anti-inflammatory Triterpenoid Blocks Immune Suppressive Function of MDSCs and Improves Immune Response in Cancer
Srinivas Nagaraj et al.
CLINICAL CANCER RESEARCH (2010)
Regulatory T Cells Interfere with Glutathione Metabolism in Dendritic Cells and T Cells
Zhonghua Yan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
HIF-1α regulates function and differentiation of myeloid-derived suppressor cells in the tumor microenvironment
Cesar A. Corzo et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2010)
Vaccination with a plasmid DNA encoding HER-2/neu together with low doses of GM-CSF and IL-2 in patients with metastatic breast carcinoma: a pilot clinical trial
Hakan Norell et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2010)
Graft-versus-host disease is enhanced by extracellular ATP activating P2X7R
Konrad Wilhelm et al.
NATURE MEDICINE (2010)
Immunosuppressive CD14+HLA-DRlow/- Monocytes in Prostate Cancer
Stanimir Vuk-Pavlovic et al.
PROSTATE (2010)
Development of Ipilimumab: Contribution to a New Paradigm for Cancer Immunotherapy
Axel Hoos et al.
SEMINARS IN ONCOLOGY (2010)
Anti-CTLA-4 Antibody Adjuvant Therapy in Melanoma
Alexander M. M. Eggermont et al.
SEMINARS IN ONCOLOGY (2010)
The Emerging Toxicity Profiles of Anti-CTLA-4 Antibodies Across Clinical Indications
Anna Maria Di Giacomo et al.
SEMINARS IN ONCOLOGY (2010)
Clinical Use of Anti-CD25 Antibody Daclizumab to Enhance Immune Responses to Tumor Antigen Vaccination by Targeting Regulatory T cells
Andrew J. Rech et al.
CANCER VACCINES (2009)
Naturally occurring regulatory T cells show reduced sensitivity toward oxidative stress-induced cell death
Dimitrios Mougiakakos et al.
BLOOD (2009)
HER-2/neu mediated down-regulation of MHC class I antigen processing prevents CTL-mediated tumor recognition upon DNA vaccination in HLA-A2 transgenic mice
Simona Vertuani et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2009)
Increased circulating myeloid-derived suppressor cells correlate with clinical cancer stage, metastatic tumor burden, and doxorubicin-cyclophosphamide chemotherapy
C. Marcela Diaz-Montero et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2009)
Genetic Regulation of the Response to Her-2 DNA Vaccination in Human Her-2 Transgenic Mice
Olga Radkevich-Brown et al.
CANCER RESEARCH (2009)
The Novel Role of Tyrosine Kinase Inhibitor in the Reversal of Immune Suppression and Modulation of Tumor Microenvironment for Immune-Based Cancer Therapies
Junko Ozao-Choy et al.
CANCER RESEARCH (2009)
Arginase I-Producing Myeloid-Derived Suppressor Cells in Renal Cell Carcinoma Are a Subpopulation of Activated Granulocytes
Paulo C. Rodriguez et al.
CANCER RESEARCH (2009)
The Impact of HER2/neu Expression Level on Response to the E75 Vaccine: From US Military Cancer Institute Clinical Trials Group Study I-01 and I-02
Linda C. Benavides et al.
CLINICAL CANCER RESEARCH (2009)
Sunitinib Mediates Reversal of Myeloid-Derived Suppressor Cell Accumulation in Renal Cell Carcinoma Patients
Jennifer S. Ko et al.
CLINICAL CANCER RESEARCH (2009)
Myeloid Derived Suppressor Cells Inhibit Natural Killer Cells in Patients with Hepatocellular Carcinoma via the NKp30 Receptor
Bastian Hoechst et al.
HEPATOLOGY (2009)
Tumor-associated macrophages and the related myeloid-derived suppressor cells as a paradigm of the diversity of macrophage activation
Alberto Mantovani et al.
HUMAN IMMUNOLOGY (2009)
Cancer-Expanded Myeloid-Derived Suppressor Cells Induce Anergy of NK Cells through Membrane-Bound TGF-beta 1
Hequan Li et al.
JOURNAL OF IMMUNOLOGY (2009)
Myeloid-Derived Suppressor Cells: Linking Inflammation and Cancer
Suzanne Ostrand-Rosenberg et al.
JOURNAL OF IMMUNOLOGY (2009)
Myeloid-Derived Suppressor Cells Down-Regulate L-Selectin Expression on CD4+ and CD8+ T Cells
Erica M. Hanson et al.
JOURNAL OF IMMUNOLOGY (2009)
Mechanism Regulating Reactive Oxygen Species in Tumor-Induced Myeloid-Derived Suppressor Cells
Cesar A. Corzo et al.
JOURNAL OF IMMUNOLOGY (2009)
Extracellular redox modulation by regulatory T cells
Zhonghua Yan et al.
NATURE CHEMICAL BIOLOGY (2009)
Myeloid-derived suppressor cells as regulators of the immune system
Dmitry I. Gabrilovich et al.
NATURE REVIEWS IMMUNOLOGY (2009)
Mononuclear myeloid-derived suppressor cells express RAE-1 and activate natural killer cells
Norman Nausch et al.
BLOOD (2008)
Abrogation of TGF beta signaling in mammary carcinomas recruits Gr-1+CD11b+ myeloid cells that promote metastasis
Li Yang et al.
CANCER CELL (2008)
Molecular mechanisms of MHC class I abnormalities and APM components in human tumors
Barbara Seliger
CANCER IMMUNOLOGY IMMUNOTHERAPY (2008)
The E75 HER2/neu peptide vaccine
Elizabeth A. Mittendorf et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2008)
Myeloid-derived suppressor cells promote cross-tolerance in B-cell lymphoma by expanding regulatory T cells
Paolo Serafini et al.
CANCER RESEARCH (2008)
Reversal of Myeloid Cell - Mediated Immunosuppression in Patients with Metastatic Renal Cell Carcinoma
Sergei Kusmartsev et al.
CLINICAL CANCER RESEARCH (2008)
A new population of myeloid-derived suppressor cells in hepatocellular carcinoma patients induces CD4+CD25+Foxp3+ T cells
Bastian Hoechst et al.
GASTROENTEROLOGY (2008)
Analysis of HLA class I expression in progressing and regressing metastatic melanoma lesions after immunotherapy
Rafael Carretero et al.
IMMUNOGENETICS (2008)
Immunoglobulin G fragment C receptor polymorphisms and clinical efficacy of trastuzumab-based therapy in patients with HER-2/neu-positive metastatic breast cancer
Antonino Musolino et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Inhibition of dendritic cell differentiation and accumulation of myeloid-derived suppressor cells in cancer is regulated by S100A9 protein
Pingyan Cheng et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2008)
Transduction with the Antioxidant Enzyme Catalase Protects Human T Cells against Oxidative Stress
Takashi Ando et al.
JOURNAL OF IMMUNOLOGY (2008)
Oxidative stress regulates expression of VEGFR1 in myeloid cells:: Link to tumor-induced immune suppression in renal cell carcinoma
Sergei Kusmartsev et al.
JOURNAL OF IMMUNOLOGY (2008)
Proinflammatory S100 proteins regulate the accumulation of myeloid-derived suppressor cells
Pratima Sinha et al.
JOURNAL OF IMMUNOLOGY (2008)
Elements related to heterogeneity of antibody-dependent cell cytotoxicity in patients under trastuzumab therapy for primary operable breast cancer overexpressing Her2
Stefania Varchetta et al.
CANCER RESEARCH (2007)
CD4+ CD25+ Foxp3+ regulatory T cells induce cytokine deprivation -mediated apoptosis of effector CD4+ T cells
Pushpa Pandiyan et al.
NATURE IMMUNOLOGY (2007)
The CD16-CD56bright NK cell subset is resistant to reactive oxygen species produced by activated Granulocytes and has higher antioxidative capacity than the CD16+CD56dim subset
Helena Harlin et al.
JOURNAL OF IMMUNOLOGY (2007)
Vascular endothelial growth factor-trap overcomes defects in dendritic cell differentiation but does not improve antigen-specific immune responses
Ingo Fricke et al.
CLINICAL CANCER RESEARCH (2007)
A combination of chemoimmunotherapies can efficiently break self-tolerance and induce antitumor immunity in a tolerogenic murine tumor model
Hyun-Jeong Ko et al.
CANCER RESEARCH (2007)
A polyepitope DNA vaccine targeted to Her-2/ErbB-2 elicits a broad range of human and murine CTL effectors to protect against tumor challenge
Antonio Scardino et al.
CANCER RESEARCH (2007)
The CD16-/CD56bright subset of NK cells is resistant to oxidant-induced cell death
Fredrik B. Thoren et al.
JOURNAL OF IMMUNOLOGY (2007)
Incidence of cancers in people with HIV/AIDS compared with immunosuppressed transplant recipients: a meta-analysis
Andrew E. Grulich et al.
LANCET (2007)
Cutting edge:: Antioxidative properties of myeloid dendritic cells:: Protection of T cells and NK cells from oxygen radical-induced inactivation and apoptosis
Fredrik B. Thoren et al.
JOURNAL OF IMMUNOLOGY (2007)
A short-term dietary supplementation with high doses of vitamin E increases NK cell cytolytic activity in advanced colorectal cancer patients
Mikael G. V. Hanson et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2007)
Identification of a new subset of myeloid suppressor cells in peripheral blood of melanoma patients with modulation by a granulocyte-macrophage colony-stimulation factor based antitumor vaccine
Paola Filipazzi et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Depletion of CD4+CD25+ human regulatory T cells in vivo:: Kinetics of Treg depletion and alterations in immune functions in vivo and in vitro
Karsten Mahnke et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression
Silvia Deaglio et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2007)
Expansion of spleen myeloid suppressor cells represses NK cell cytotoxicity in tumor-bearing host
Cunren Liu et al.
BLOOD (2007)
Chemoprevention by cyclooxygenase-2 inhibition reduces immature myeloid suppressor cell expansion
James E. Talmadge et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2007)
Reversal of tumor-mediated immunosuppression
Johannes Vieweg et al.
CLINICAL CANCER RESEARCH (2007)
Oxidative stress and cancer: have we moved forward?
Barry Halliwell
BIOCHEMICAL JOURNAL (2007)
Natural regulatory T cells: mechanisms of suppression
Makoto Miyara et al.
TRENDS IN MOLECULAR MEDICINE (2007)
Distinct and non-overlapping T cell receptor repertoires expanded by DNA vaccination in wild-type and HER-2 transgenic BALB/c mice
Simona Rolla et al.
JOURNAL OF IMMUNOLOGY (2006)
Phosphodiesterase-5 inhibition augments endogenous antitumor immunity by reducing myeloid-derived suppressor cell function
Paolo Serafini et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2006)
Tumors induce a subset of inflammatory monocytes with immunosuppressive activity on CD8+ T cells
Giovanna Gallina et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
All-trans-retinoic acid improves differentiation of myeloid cells and immune response in cancer patients
Noweeda Mirza et al.
CANCER RESEARCH (2006)
CD80 in immune suppression by mouse ovarian carcinoma-associated Gr-1+CD11b+ myeloid cells
Rongcun Yang et al.
CANCER RESEARCH (2006)
Regulatory T cells, tumour immunity and immunotherapy
WP Zou
NATURE REVIEWS IMMUNOLOGY (2006)
Gr-1+CD115+ immature myeloid suppressor cells mediate the development of tumor-induced T regulatory cells and T-cell anergy in tumor-bearing host
B Huang et al.
CANCER RESEARCH (2006)
Regulation of dendritic cell differentiation and antitumor immune response in cancer by pharmacologic-selective inhibition of the Janus-activated kinase 2/signal transducers and activators of transcription 3 pathway
Y Nefedova et al.
CANCER RESEARCH (2005)
Gemcitabine selectively eliminates splenic Gr-1+/CD11b+ myeloid suppressor cells in tumor-bearing animals and enhances antitumor immune activity
E Suzuki et al.
CLINICAL CANCER RESEARCH (2005)
Preferential cell death of CD8+ effector memory (CCR7-CD45RA-) T cells by hydrogen peroxide-induced oxidative stress
A Takahashi et al.
JOURNAL OF IMMUNOLOGY (2005)
Regulatory T cells in immunologic self-tolerance and autoimmune disease
S Sakaguchi et al.
INTERNATIONAL REVIEWS OF IMMUNOLOGY (2005)
Early role of CD4+ Th1 cells and antibodies in HER-2 adenovirus vaccine protection against autochthonous mammary carcinomas
JM Park et al.
JOURNAL OF IMMUNOLOGY (2005)
Inhibition of CD4+25+ T regulatory cell function implicated in enhanced immune response by low-dose cyclophosphamide
MEC Lutsiak et al.
BLOOD (2005)
Adoptive cell transfer therapy following non-myeloablative but lymphodepleting chemotherapy for the treatment of patients with refractory metastatic melanoma
ME Dudley et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Nitroaspirin corrects immune dysfunction in tumor-bearing hosts and promotes tumor eradication by cancer vaccination
C De Santo et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Phase 1B study to improve immune responses in head and neck cancer patients using escalating doses of 25-hydroxyvitamin D3
DMR Lathers et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2004)
Mhc class I antigen processing pathway defects, ras mutations and disease stage in colorectal carcinoma
D Atkins et al.
INTERNATIONAL JOURNAL OF CANCER (2004)
CD4+T cell-mediated HER-2/neu-specific tumor rejection in the absence of B cells
JA Lindencrona et al.
INTERNATIONAL JOURNAL OF CANCER (2004)
Antigen-specific inhibition of CD8+ T cell response by immature myeloid cells in cancer is mediated by reactive oxygen species
S Kusmartsev et al.
JOURNAL OF IMMUNOLOGY (2004)
Cancer immunotherapy: moving beyond current vaccines
SA Rosenberg et al.
NATURE MEDICINE (2004)
Identification of HER2/neu-derived peptides capable of inducing both cellular and humoral immune responses in HLA-A24 positive breast cancer patients
K Azuma et al.
BREAST CANCER RESEARCH AND TREATMENT (2004)
Small interfering RNA (siRNA) inhibits the expression of the Her2/neu gene, upregulates HLA class I and induces apoptosis of Her2/neu positive tumor cell lines
A Choudhury et al.
INTERNATIONAL JOURNAL OF CANCER (2004)
HER-2/neu-mediated regulation of components of the MHC class I antigen-processing pathway
F Herrmann et al.
CANCER RESEARCH (2004)
Human ErbB-2 (Her-2) transgenic mice: A model system for testing Her-2 based vaccines
MP Piechocki et al.
JOURNAL OF IMMUNOLOGY (2003)
Vaccination with cytoplasmic ErbB-2 DNA protects mice from mammary tumor growth without anti-ErbB-2 antibody
SA Pilon et al.
JOURNAL OF IMMUNOLOGY (2001)
Inhibition of activated/memory (CD45RO+) T cells by oxidative stress associated with block of NF-κB activation
KJ Malmberg et al.
JOURNAL OF IMMUNOLOGY (2001)
Increased production of immature myeloid cells in cancer patients: A mechanism of immunosuppression in cancer
B Almand et al.
JOURNAL OF IMMUNOLOGY (2001)
Transcriptional regulation of the major histocompatibility complex (MHC) class I heavy chain, TAP1 and LMP2 genes by the human papillomavirus (HPV) type 6b, 16 and 18 E7 oncoproteins
NT Georgopoulos et al.
ONCOGENE (2000)
Resection of solid tumors reverses T cell defects and restores protective immunity
S Salvadori et al.
JOURNAL OF IMMUNOLOGY (2000)
Inhibitory Fc receptors modulate in vivo cytoxicity against tumor targets
RA Clynes et al.
NATURE MEDICINE (2000)
分享论文
